The observation that the risk factors included in the score are particularly significant among heart failure patients without atrial fibrillation is an important result, study authors said. ... Patients with heart failure had a high risk of ischemic
Ularitide, an intravenous synthetic form of the renal vasodilatory natriuretic peptide urodilatin, did not improve mortality among patients with acute heart failure, a recent trial found. ... The double-blind, industry-funded trial randomized 2,157
Patients with heart failure may do better when readmitted to the same versus to a different hospital, according to a new study. ... The top five causes for readmission were heart failure, chronic obstructive pulmonary disease, acute myocardial infarction,
The patients had New York Heart Association (NYHA) Class III or IV heart failure. ... The association between VTE risk and heart failure severity was seen in the overall group and the enoxaparin subgroup but not the rivaroxaban subgroup.
Many more elderly patients with heart failure have cognitive impairment than their treating cardiologists realize, a recent study found. ... The study found an association between greater memory impairment and more severe heart failure class.
Nine interventions for transitions of care in heart failure may assist in achieving optimal clinical and patient-centered outcomes, according to a scientific statement that addressed patient, hospital, and clinician barriers. ... Ensure that qualified
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Readmissions for heart failure, bleeding, ischemic stroke, stroke, and other cardiovascular causes were not significantly different between the groups. ... We observed a mortality rate >40% at 1 year and 70% by 3 years among untreated patients with heart
Oral β-blockers should be given to all patients with acute coronary syndrome without a contraindication (decompensated heart failure, advanced atrioventricular block, or severe reactive airways disease) and continued indefinitely. ... Based on the
Beta-blockers not associated with lower risk of death after acute MI in patients without heart failure
Beta-blocker use was not associated with lower mortality up to one year after discharge in patients with acute myocardial infarction (MI) but without heart failure (HF), a recent study found.
A metric of diuretic efficiency provided better prognostic information about decongestive treatment for acute decompensated heart failure than did fluid output or diuretic dose, a new study found. ... the multi-site Evaluation Study of Congestive Heart